Skip to main content
. 2021 Dec 30;23(1):392. doi: 10.3390/ijms23010392

Table 1.

Content curation of long-non-coding RNA (lncRNA) and its targeting microRNA (miRNA) and related mechanism of castration resistance prostate cancer.

Mechanism of Castration Resistance Subject Investigated (Cell Lines/Tissue) lncRNA miRNA Interactions Reference
AR amplification 22RV1/human PCa PlncRNA-1 miR-34c/miR-297 PlncRNA-1 promotes AR expression via competitive inhibition of miRNA-34c/miR-297 targeting AR. [57]
Increased AR transcriptional activity PC3, DU145/human PCa CCAT1 miR-28-5P In cytoplasm: competing for miR-28-5P to promote cell proliferation and colony formation. [58]
In nucleus: CCAT1 acts as a scaffold for DDX5(P68) and AR transcriptional complex to facilitate expression of AR-regulated castration resistance gene (UBE2C).
Signal cascades independent of AR and crosstalk with AR Growth factors C4-2, PC3, DU145 AFAP1-AS1 miR-15b AFAP1-AS1 upregulates IGF1R by competitively binding with miR-15b to de-repress IGF1R. [59]
human PCa PTTG3P miR-146a-3p PTTG3P upregulates PTTG1 to stimulate FGF expression by competing for miR-146a-3p. [60]
Other oncogenic signal pathways PC3 SChLAP1 miR-198 SChLAP1 regulates the miR-198 expression and influences cancer progression by the MAPK1 pathway. [61]
human PCa Linc00963 miR-655 Linc00963 competitively binds with miR-655 and upregulates TRIM24 expression to activate the PI3K/AKT pathway. [62]
PC3, DU145/human PCa MYU(VPS9D1-AS1) miR-184 MYU upregulates the MYC expression by competitively binding with miR-184. [63]
Cell cycle dysregulation DU145/human PCa SNHG7 miR-503 MiR-503 targets 3′-UTR of SNHG and inhibits cell cycle proteins (CDK4, CDK6, Cyclin D), inducing G0/G1 cell cycle arrest. [64]
PC3, DU145 LOXL1-AS1 miR-541-3p LOXL1-AS1 interferes with miR-541-3p targeting cell cycle regulator Cyclin D and promotes cell proliferation. [65]
DU145/human PCa TTTY15 let-7 FOXA1, acting as a transcription factor of TTTY15, promotes PCa progression by sponging let-7 and upregulating CDK6 and FN1. [66]
Cytokine C4-2, PC3, DU145 SNHG17 miR-144 SNHG17 acts as a ceRNA to upregulate CD51 (integrin alpha-V) expression through competitively sponging miR-144. [67]
Unidentified mechanisms PC3, DU145 HOTAIR miR-34a MiR-34a directly targets HOTAIR and inhibits cell growth. [68]
PC3 HOTAIR miR-193a HOTAIR couples with EZH2 to repress miR-193a by trimethylation of H3K27me3; miR-193a directly targets HOTAIR to reduce HOTAIR level in miR-193a overexpressed cells. [69]
PC3 PCGEM-1 miR-148a Putative PCGEM1 binding site is identified in the 5′-UTR of miR-148a; PCGEM-1 expression represses miR-148a and cell apoptosis. [70]
PC3, DU145/human PCa PCSEAT miR-143-3p-/miR-24-2-5p PCSEAT competitively sponges miR-143-3p/miR-24-2-5p and decreases PCSEAT-mediated cell proliferation. [71]
PC3, DU145/human PCa Linc00308 miR-137 LncRNA-miRNA-mRNA networks regulate tumor suppressor gene PTGS2 and DUSP2 and affect survival. [72]
Linc00355 miR-122/miR-506
OSTN-AS1 miR-137/miR-506

AR: Androgen receptor; FGF: fibroblast growth factor; FN1: fibronectin; IGF1R: insulin-like growth factor 1 receptor; PCa: prostate cancer; ceRNA: competing endogenous RNA.